another by means of a number of neurotransmitters and neuropeptides, although functional roles are not yet understood. Here, we characterize the presence, distribution pattern, phenotype, and functional consequences of a previously undescribed inhibitory route within the taste bud mediated by the classic neurotransmitter GABA and its receptors. By using immunocytochemistry, subsets of TRCs within rat taste buds were identified as expressing GABA, and its synthetic enzyme glutamate decarboxylase (GAD). GAD expression was verified with Western blotting. Immunofluorescent studies revealed complex coexpression patterns of GAD with the TRC protein markers gustducin, neural cell adhesion molecule, protein gene product 9.5, and synaptosomal-associated protein of 25 kDa that collectively outline hardwired signaling pathways of GABAergic TRCs. RT-PCR and immunocytochemistry demonstrated that both GABA A and GABAB receptors are expressed in the taste bud. The later was observed in a subset TRCs paracrine to GAD-expressing TRCs. Physiological effects of GABA were examined by patch clamp recordings. GABA and the GABAA agonists muscimol and isoguvacine enhanced isolated chloride currents in a dose-dependent manner. Also, GABA and the GABAB agonist baclofen both elicited increases of the inwardly rectifying potassium currents that could be blocked by the GABAB receptor antagonist CGP 35348 and the G protein blocker GDP-␤S. Collectively, these data suggest that GABAergic TRCs are able to shape the final chemosensory output of the bud by means of processes of cell-to-cell modulation.
R
ecent studies of gustatory transduction (1, 2) have dramatically altered our understanding of how the taste bud operates. Early views of taste-bud function were based on anatomical studies and classified taste receptor cells (TRCs) into types I, II, or III. Type III cells are synaptically connected to afferent nerve fibers and were considered as ''true'' receptor cells, because they communicate directly with the central nervous system. Types I and II, differing in their opacity (dark or light, respectively) lack synapses, and were considered supportive cells. The discovery of the 7 transmembrane receptor families T1R and T2R and other downstream signaling molecules in type II cells changed the view that single TRCs operate in isolation but instead function collectively through cell-to-cell communication in producing the neural output (3, 4) . The notion has lead to discussing transduction as early, or primary, events leading to activation of late, or secondary, events. Early events involve steps leading to the activation (i.e., depolarization) of an individual TRC. Tastant molecules interact with receptors of the T1R or T2R families in type II cells or with ion channels such as the trp channel PDKL2 in type III cells or ENaCs, possibly in type I cells. Events after the depolarization of the TRC that constitute the late events remain obscure. A number of neurotransmitters, neuropeptides, and their corresponding receptors form intricate hard-wired pathways in the bud for information processing. Some examples of cell-to-cell communication in the taste bud include serotonin (5, 6) , norepinephrine (7, 8) , ATP (9) , cholecystokinin (10) , and neuropeptide Y (11) . It is believed that activation of TRCs results in information processing within the bud and ultimate activation of the afferent nerve fibers. How these hardwired transmitter pathways participate with qualityspecific tastant sensations remains a seminal unanswered question.
The surplus of neurotransmitters and neuropeptides in the taste bud likely allows TRCs with similar and different tastant sensitivities to communicate along excitatory and inhibitory routes. Here, we look at a previously uncharacterized putative inhibitory pathway, GABA. An earlier immunocytochemistry study suggested that GABA, as well as the membrane transporter for GABA-uptake, GAT3, is expressed in a subset of taste-bud cells in the rat circumvallate papillae (12) . Also, the expression of GAD1 mRNA, one isoform of the synthetic enzyme for GABA, was observed in murine taste buds (13) . We extend these observations to outline an inhibitory pathway for GABA within the bud that includes phenotypic GABA expression in a subtype of type II cell, expression of both GABA A and GABA B receptors, postsynaptic relationship of GABA and GABA B receptors, and activation of these receptors results in inhibitory actions on TRCs.
Results

GABA and Its Synthetic Enzyme GAD Are Expressed in TRCs.
By using an antibody directed against GABA, GABA-like immunoreactivity was observed in subsets of TRCs located in both the foliate (FOL) and the circumvallate papillae (CV) of the rat tongue ( Fig. 1 Left) . These findings independently confirm those of Obata et al. (12) , and suggest that TRCs could serve as the endogenous source of GABA within taste buds. Positively stained TRCs displayed an elongate, spindle shape with a large round or oval nucleus with immunolabeling, extending the entire cellular process from the apical tip to the basement membrane. No obvious differences in morphology of GABA-like immunoreactive TRCs between FOL and CV were observed. ImmuAuthor contributions: Y.C., F.-l.Z., and S.H. designed research; Y.C., F.-l.Z., T.K., and R.H. performed research; Y.C., F.-l.Z., T.K., R.H., and S.H. analyzed data; and Y.C. and S.H. wrote the article.
nopositive cells were often observed in the central area of the bud. Of 681 total taste buds observed, 844 immunopositive TRCs were observed in 562 buds. Thus, 82% of taste buds observed in an 8-m section had immunopositive cells with an average of 1.6 Ϯ 0.04 stained cells per taste bud cross-section [see supporting information (SI) Table S1 ]. Immunocytochemistry on cerebellum (CE) was performed as a positive control tissue and elimination of primary antiserum eliminated staining.
To further confirm the presence of GABA in TRCs, expression of its synthetic enzyme glutamate decarboxylase (GAD) was examined with Western blotting and immunocytochemistry by using an antibody that recognizes both 65 and 67-kDa GAD isoforms (GAD65/67). Immunoreactive bands of appropriate size were observed on membrane-transferred total protein extracts from anterior or posterior tongue (PT) (Fig. 1) . Protein extracts from cerebral cortex (CTX) and CE served as positive control. GAD immunopositive TRCs were observed in anterior and posterior taste buds. These cells were highly reminiscent of GABA-immunoreactive TRCs with elongate, spindle shape and a large round or oval nucleus. Representative GADimmunopositive cells from CV are presented in Fig. 1 
Right.
Other examples for anterior and posterior taste buds are presented in Fig. S1 . Only slight differences were noted in cell counts between the GABA and GAD65/67 experiments. Of 1,083 observed sectioned taste buds, 1,453 immunopositive TRCs were observed in 831 buds. Thus, 76% of buds had immunopositive cells with an average of 1.8 stained cells per cross-sectioned taste bud (Table S1 ). Thus, these 2 populations of immunopositive cells were quantitatively similar. Double labeling immunocytochemistry experiments were performed to phenotype these cells. GAD65/67-immunoreactivity was used as a marker for GABAergic TRCs, because GABAimmunocytochemistry required glutaraldehyde fixation, precluding its usage in double-labeling protocols. Comparison of expression patterns of GAD65/67 TRCs with common phenotypic markers of TRCs, including ␣-gustducin (␣-gust), neural cell adhesion molecule (NCAM), protein gene product 9.5 (PGP 9.5), and synaptosomal-associated protein (SNAP-25), were explored.
GAD65/67-immunoreactive cells demonstrated virtually no overlapping expression with either NCAM or PGP 9.5-immunopositive TRCs in posterior tissue. Photomicrograph examples are presented in Fig. S2 . NCAM and PGP 9.5 are highly overlapping markers (14) . These cells have slender elongate shape and a relatively narrow nuclear region, and are distinct from ␣-gust expressing TRCs. Many coexpress serotonin, and are suggested to represent TRCs that directly synapse with afferent nerve fibers (i.e., type III cells). PGP 9.5-immunoreactivity is expressed in a subset of TRCs that coexpress NCAM, form synapses with afferent nerves, but do not display 5-HT-immunoreactivity, as well as a separate group of TRCs that do not form synapses and do not express ␣-gust (15) . These findings imply that GABA is not expressed in TRCs with direct afferent connections, and that GABA and 5-HT are unlikely to be coexpressed in the same TRC.
In contrast, over half of the GAD65/67-immunopositive TRCs also displayed ␣-gust immunoreactivity. Of 147 examined crosssectioned taste buds, 269 TRCs were immunopositive for GAD65/67 and 531 TRCs for ␣-gust. Of these labeled TRCs, 146 cells were observed to express immunoreactivity for both antigens. Thus, 54% of all GAD65/67 positive cells also expressed ␣-gust (Table S2 ). This colocalization pattern suggests that some of the GABAergic TRCs are capable of transducing taste signals such as sweet or bitter stimuli.
GAD-immunopositive cells were further phenotyped with SNA P-25. Extensive overlap of GAD-and SNA P-25-immunopostivie cells was observed (Fig. S2 ). In these experiments, we examined 98 taste buds that contained 192 TRCs immunopositive for GAD65/67 and 347 TRCs immunopositive for SNAP-25. Within these labeled cells, 138 cells were immunopositive for both antigens. Thus, 71% of all GAD65/67 TRCs coexpressed SNAP-25 (Table S2 ), suggesting that most GABAergic TRCs are able to use regulated exocytosis as a mechanism for releasing endogenous neuroactive substances. A summary of observed colocalization patterns is presented in Table S3 .
Expression of the GABAA Receptor ␣1 Subunit in TRCs. The expression of GABA A receptor subunits was examined by using RT-PCR, Western blotting, and immunocytochemistry. The ␣1 and ␣3 subunits were targeted for initial study, because, in the mammalian brain, the ␣1 subunit is the most abundant GABA A receptor subunit, whereas the ␣3 subunit is expressed in brain regions with low levels of the ␣1 subunit (16) .
To test for expression of either ␣1 or ␣3 GABA A receptor subunit mRNA, PCR was performed on cDNA reverse transcribed from RNA extracted from CV lingual epithelium containing taste buds. Reactions were optimized on cDNA reverse transcribed from RNA extracted from CTX or hypothalamus. Results are presented in Fig. 2 Top. PCR product of correct size was obtained in reactions by using primers specific for the ␣1 (expected size 511 bp), but not for the ␣3 subunit (expected size 325 bp) from taste tissue. For all PCR reactions, a parallel reaction was conducted that omitted the reverse transcriptase step (RT-) to ensure that observed PCR products were not derived from genomic template. A primer set for the housekeeping gene ␤-actin that spanned its third intron was also included to control for genomic contamination.
Western blotting experiments were performed on membrane protein samples prepared from CV, FOL, anterior tongue (AT), CTX, and CE. CTX and CE served as positive control tissues. As illustrated (Fig. 2 Bottom), immunoreactive bands to the antibody against the ␣1 subunit was detected in membrane protein extracts of both anterior and posterior taste papillae. However, evidence for the presence of ␣3 protein in lingual tissue was not observed.
By using immunocytochemistry, ␣1 subunit-immunoreactivity was confirmed in a small subpopulation of TRCs in rat posterior lingual epithelium. On average, Ϸ2/3 of the taste buds identified on an 8-m cross-section of either FOL or CV contained cells positively labeled by the ␣1 subunit antibody. In 301 examined taste buds, 202 buds (67%) exhibited 316 stained cells for an average of 1.62 Ϯ 0.08 cells (mean Ϯ SE) in an 8-m crosssectional area. As shown in Fig. 2 , ␣1 subunit-immunopositive TRCs typically exhibited morphological features similar to those of the TRCs identified to express signal transduction molecules. These ␣-1 immunopositive cells were elongate with a circular or oval nuclear region and processes extending from the apical end to the basement membrane of the taste buds. No significant immunoreactivity to the GABA A receptor ␣1 subunit was recognized in any of the nerve fibers inside or under the taste buds, and the epithelium surrounding the taste buds lacked any specific immunostaining. Unfortunately, this antibody was not feasible for double labeling immunocytochemical experiments and, thus, prevented further phenotyping of these cells.
However, ␣-3 subunit-immunoreactivity was absent in any of the taste buds examined. Forebrain sections that served as positive controls for localization of the ␣3 subunit-immunoreactivity were processed in parallel with lingual sections of the same animal. Despite of failure to detect any ␣3 subunitimmunoreactivity in the tongue sections, numerous ␣3 subunitimmunoreactive neurons were observed in the forebrain sections. Collectively, these data suggest that subsets of TRCs express the GABA A receptor subtype, whose subunit composition includes the ␣1 subunit. However, the ␣3 subunit is unlikely to be present in taste buds.
GABA Enhances Chloride Currents in TRCs.
The expression pattern of GABA, GAD, and the ␣1 subunit of the GABA A receptor predicts that exogenous stimulation of TRCs expressing GABA receptors with GABA should result in physiological responses, in particular enhancement of chloride current. To test this hypothesis, chloride currents were isolated from acutely dissociated TRCs by using patch clamp recordings. Chloride currents were evoked by using a ramp command protocol (Ϫ130 to 120 mV, 250 mV/sec) from a holding potential of 0 mV in potassiumfree ECF and ICF solutions as previously described (7) . The evoked currents displayed characteristics of previously described currents such as outward rectification, outward amplitudes (Ͻ200 pA), inhibition by various chloride channel blockers including 4-acteamido-4Ј-isothiocyanastilbene-2,2Ј-disuldonic acid (SITS), niflumic acid, or 9-anthracene carboxylic acid (9-AC, each tested at 500 M), calcium dependence, and modulation by norepinephrine (7) .
Focal application of GABA (30 to 2,000 M) enhanced both outward and inward portions of chloride currents in a reversible concentration-dependent manner with half maximal effect occurring Ϸ16 M. A representative current trace is presented in Fig. 3 Upper (500 M). Similar to adrenergic modulation of chloride currents, GABA at lower concentrations (e.g., 30 M) appeared to affect the outwardly rectifying portion of the chloride currents with enhancement of the inward portion more significant at higher GABA concentrations. Current amplitude increased by Ϸ25% peaking to 35% maximum Ϸ300 M GABA and declining somewhat at higher concentrations (Fig. 3 Lower) . Given the high input resistance of TRCs, such enhancement would produce a significant hyperpolarization of the membrane potential. Increasing GABA concentration also increased the number of responding cells from 15% (30 M, 3 of 21) to 30% (2,000 M, 7 of 22). These observations are consistent with receptor-mediated current activation.
GABAA Receptor Agonists Mimic the Effects of GABA on Chloride
Currents. The GABA A receptor-specific agonists muscimol and isoguvacine were tested at varying concentrations to examine this role of receptor subtype in the GABA enhancement of chloride currents. Application of either muscimol or isoguvacine mimicked the GABA enhancement in a concentration- (Fig. 4B ). As observed with other pharmacological manipulations of taste cells, the increase of muscimol concentration produced a small increase in the number of responding cells from Ϸ14% at 10 M to Ϸ30% cells at 100 M (Fig. 4B) . Similarly, isoguavacine enhancement was dose dependent and increased the chloride current to a maximum observed value of 140% tested at 500 M. Also, slightly more cells were responsive to isoguavacine (Ϸ40%) than to muscimol.
Expression of the GABAB Receptors in TRCs.
Putative expression of the GABA B receptor subtype in rat taste buds was investigated by using immunocytochemistry and RT-PCR. By using an antibody against the R1 subunit of the GABA B receptor, immunoreactivity was observed in spindle-shaped TRCs that demonstrated similar morphological characteristics to those of GABA-, GAD65/67-, or GABA A -receptor ␣1 subunit-immunoreactive cells (Fig. 5 Top) . Of 942 total cross-sectioned taste buds examined, TRCs immunopositive for GABA B R1 were observed in 477 buds. Within these buds, a total of 581 immunopositive TRCs were observed, or Ϸ1.2 cells per sectioned bud. Thus, fewer positively labeled cells were observed in a single taste bud cross-sectional area when compared with that of GABA-, GAD65/67-, or GABA A -receptor ␣1 subunit-immunoreactive TRCs.
Primer sets specific for either the R1 or R2 subunits of the GABA B receptor were used for PCR analysis (expected product sizes 209 and 466 bp, respectively). Each set was optimized on brain tissue (CTX) known to express these receptor subunits. For all PCR, a parallel reaction was conducted that omitted the reverse transcriptase step to ensure products were not derived from genomic template as well as a ␤-actin primer set that spanned an intron. For both primer sets, amplification products of correct size were obtained in PCR performed on cDNA reverse transcribed from lingual tissue containing taste buds. Results are presented in Fig. 5 Middle.
Because GABA B receptors may be expressed either pre or postsynaptically, double labeling immunocytochemical experiments by using the GAD65/67 antibody as a marker for GABAergic TRCs and a GABA B R1 subunit antibody were conducted to examine their relationship. In these experiments, GAD65/67 and GABA B receptor R1-immunoreactive TRCs labeled nonoverlapping populations (Fig. 5 Bottom) , indicating a paracrine role of GABA mediated by the GABA B receptors. In no experiments were overlapping cells observed. Further phenotyping the GABA B -expressing TRC was conducted by examining the colocalization patterns with ␣-gust or SNAP-25 by using the GABA B R1 subunit antibody. In these experiments, no overlap was observed between GABA B -R1 and ␣-gust immunopositive TRCs (Fig. S3) . However, Ͼ70% of the TRCs displaying immunoreactivity to the GABA B receptor R1 subunit also demonstrated SNAP-25-immunoreactivity, whereas no Ͼ1/4 of the SNAP-25-expressing TRCs also expressed the GABA B receptor R1 subunit (Table S2) . Therefore, most of the GABA B receptor R1 subunit in the taste buds appeared to be expressed by TRCs with synapses and capable of releasing neuroactive substances by means of regulated exocytosis.
GABA and GABAB Receptor Agonists Enhance a Potassium Current in
TRCs. Postsynaptic GABA B receptors produce hyperpolarizing effects by opening K IR channels. Consequently, we tested potential GABA B -mediated actions in TRCs by isolating K IR currents from dissociated cells. Recorded K IR currents displayed features as previously described (17), such as activation on membrane hyperpolarization, strong inward rectification, voltage dependence, extracellular potassium concentration dependence, and blockage by cesium or barium. When applied focally, exogenous GABA (500 M to 2 mM) effectively enhanced the current magnitude of the inwardly rectifying portion of the K IR current in a subset of TRCs (Fig. 6A) . Current magnitudes were enhanced by 120 to 130% of control values with enhancement increasing with increasing GABA concentration (500 M 120%, 3/14 cells; 1 mM, 123%, 5/24 cells; 2 mM, 130%, 7/23 cells). The current magnitude enhancement was only partially reversible with washout of GABA from the bathing solution during the recording session, not unexpected for activation of metabotropic receptors.
To examine involvement of specific receptor subtypes in K IR enhancement, both the GABA B receptor-specific agonist baclofen and GABA B antagonist CGP35348 were tested. Baclofen mimicked the effect of GABA on K IR in both magnitude of effect and number of cells affected (Fig. 6B) . Baclofen, at 500 M, increased the magnitude of K IR to 131 Ϯ 3.5% of its original value (n ϭ 19/59 tested cells), and the enhancement was reversible on rinse. Similar results were observed with 1-mM Baclofen (Fig. 6C) .
As further evidence of the involvement of GABA B receptors, the antagonist CGP 35348 was tested on 10 cells, which were first demonstrated to respond to 500 M Baclofen. When Baclofen was applied in the presence of CGP 35348 (500 M), only 1 of 10 tested cells still displayed increased current magnitude of K IR (Fig. 6D) , suggesting that actions of Baclofen are occurring on the GABA B receptor subtype.
Because the GABA B receptor is metabotropic, G protein involvement in the modulation of K IR was tested with pretreatment with GDP-␤S (2 mM), a nonhydrolyzable GTP analogue that inactivates G proteins by irreversibly binding to the alpha subunit. Treatment with GDP-␤S abolished enhancing effects of Baclofen on K IR (n ϭ 19 cells; Fig. 6D) . Last, receptor desensitization, a general feature for G protein-coupled receptors, was observed with repeated stimulation of the GABA B receptor with either GABA or Baclofen as a significant reduction of response amplitude with consecutive drug applications.
Discussion
Collectively, these data identify GABA as an endogenous inhibitory neurotransmitter within the rat taste bud. Immunocytochemical results using antibodies against GABA or its synthetic enzyme, GAD, suggest that GABA is expressed in a subset of TRCs within the bud. These data corroborate those by Obata et al. (12) , who provided the first immunocytochemical demonstration of GABA expression in posterior rat TRCs, as well as DeFazio et al. (13) , who reported, using single-cell RT-PCR, GAD1 (aka GAD67) mRNA expression in a subset of murine TRCs. Our data subsequently further phenotyped the expression of GAD-immunopositive TRCs, reported and characterized expression of GABA receptors in TRCs, and documented the physiological actions of receptor activation. RT-PCR and immunocytochemical experiments strongly support expression of both GABA A and GABA B receptors within the bud. Although technical limitations prevented the examination of the relationship of GABA A -and GAD-expressing cells, GABA B receptors were paracrine to GAD-expressing cells, establishing a hardwired pathway within the bud for GABA signaling. Patch clamp recordings of isolated ionic currents further confirmed that receptor activation with either exogenously applied GABA or receptor-specific agonists resulted in inhibitory actions. Collectively, these data suggest GABA is synthesized in a subset of TRCs and that GABA can produce functional physiologically inhibitory responses mediated by GABA receptors.
Although these data establish that GABA has an inhibitory role in cell-to-cell signaling within the taste bud, its relationship to the processing of tastant information is poorly understood. Based on this study, GABA is expressed in a subset of TRCs that mostly express ␣-gust and SNAP-25, but neither NCAM nor PGP9.5. These observations would exclude GABA expression from type III cells and restrict it to type II cells. In contrast, DeFazio et al. (13) also demonstrated GAD1 and SNAP25 coexpression, but concluded, using SNAP-25 as a type III specific marker, that these molecules were expressed in murine type III cells. In the rat, 3 independent laboratories have documented SNAP25 expression in rat type II cells based on coexpression patterns with other type II markers such as gustducin (18, 19) , PLC␤2 (19) , and PLA2-IIA (20) . Interpretation of whether GAD is expressed in type II and/or type III cells may be due to different SNAP-25 expression patterns in rat and mouse taste buds, and additionally may point to imperfections inherent in this classification system, particularly across species. If patterns were defined by criteria other than anatomy, such as receptor expression or age of TRCs, there might be no discrepancy. Another confounding variable for double labeling studies involves cell turnover. Incomplete overlap patterns of 2 functionally connected molecules would be expected if each is expressed at different times during the life of a cell. Unless the expression of 2 signaling agents was timed coincidentally, incomplete overlap would be observed in immunocytochemical double labeling. However, as long as both were expressed when required by the mature cell, their incomplete double labeling patterns does not undermine their functional connectedness. For example, incomplete overlap of GAD and gustducin would be expected if their expressions were not completely coincident during taste cell maturation. However, the 2 pathways (tastantinduced gustducin stimulation and GABA release) might still be tightly coupled functionally.
Our data suggest that GABAergic TRCs would be able to respond directly to tastant stimulation, e.g. bitter and sweet, and therefore participate in signal processing within the taste bud. Two possibilities are likely: lateral inhibition and/or gain modulation. The observations that GAD-positive cells overlap extensively with gustducin whereas GABA B R1-cells do not, and that GAD-and GABA B R1-positive cells do not colocalize, lend credence to the notion that GABA and GABA B cells are distinct functional populations. This wiring pattern suggests that GABA could be released from TRCs expressing G protein coupled receptors and act to inhibit other TRCs in a form of lateral inhibition. Thus, stimulation of one taste quality (e.g., bitter) could inhibit TRCs expressing receptors of a different taste quality (e.g., sweet) by means of a paracrine GABA action. In this manner, inhibitory pathways could serve as a peripheral basis for mixture suppression. GABA may also participate in gain modulation during taste stimulation. Stimulus-induced release of GABA could act to limit excitation by reducing a depolarizing potential, limiting the duration of the action potential, or hyperpolarizing the membrane potential. Any could extend the dynamic range of the taste bud responsiveness to tastants. Phenotyping expression of GABA receptors (especially GABA A receptors) will be an important next step toward fully understanding the role of GABA.
Last, the expression of GABA and its receptors in TRCs adds to a growing list of neurotransmitters and neuropeptides expressed within the bud that include ACh (21), ATP (9), NE (8, 22) , serotonin (6, 23) , cholecystokinin (10), GLP-1 (24) , and neuropeptide Y (11). Collectively, their occurrence has changed views of taste-bud mechanisms from one of parallel independent processing units to a more unified collective unit involving extensive cell-to-cell interactions.
Materials and Methods
Animals. Experiments were performed on adult male Sprague-Dawley rats. All procedures were approved by the University Laboratory Animal Care and Use Committee and adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Gustatory papillae were harvested for either immunocytochemical or electrophysiological investigation after animals reached a surgical level of anesthesia by using 0.09 mL/100 gm body weight of a 91 mg/mL ketamine/0.09-mg/mL acepromazine mixture before euthanasia.
Immunocytochemistry. Single or double-label immunocytochemistry and cell count analysis were performed on paraffin embedded Bouin's fixed lingual papillae according to previously published fluorescent protocol (6) . A more detailed protocol along with sources of primary antibodies and dilutions may be found in SI Materials and Methods and Table S4 .
Western Blot Analysis. Excised blocks of gustatory and nongustatory epithelium were homogenized in homogenization buffer, and supernatants were stored at Ϫ20°C. For membrane preparations, homogenates were first centrifuged at 1,960 ϫ g at 4°C for 10 min, and supernatants transferred to clean tubes then centrifuged again at 20,800 ϫ g at 4°C for 1 h. Pellets (containing membranous proteins) were resuspended in homogenization buffer and stored at Ϫ20°C.
Protein concentration was determined by using the Bio-Rad RC-DC protein assay kit. Proteins were transferred to 0.22-m PVDF membranes (100 V, 45 min), rinsed, blocked, and incubated in primary antibody overnight at 4°C. Blots were visualized by using a chemiluminecent detection kit (SuperSignal West Femto Maximum Sensitivity Substrate, Pierce Biotechnology) and exposed to X-ray films (Hyperfilm MP, Amersham Biosciences).
RT-PCR.
RT-PCR experiments were performed on total RNA isolated from 20 to 50 individually harvested CV taste buds according to our previously published protocol (6) . The PCR profile was 94°C at 5 min (1 cycle), 94°C at 30 sec, 55°C at 30 sec, 72°C at 45 sec (35 cycles), and 72°C at 10 min (1 cycle). Primer sequences and further details may be found in SI Materials and Methods.
Physiological Analysis. Patch clamp experiments were performed on TRCs dissociated from CV and FOL as previously described (5, 10) . Chloride or KIR currents were isolated as previously described (7, 17) . Data were analyzed with a combination of off-line software programs that included a software acquisition suite (pCLAMP; Axon Instruments) and a technical graphics/analysis program (Origin 7.5; MicroCal Software). Further details may be found in SI Materials and Methods.
